Quest Diagnostics Raises FY2026 GAAP EPS Guidance from $9.97-$10.17 to $10.21-$10.31 vs $10.15 Est
Benzinga Newsdesk 1 week ago
NewsGuidance
Quest Diagnostics (NYSE:DGX) raises FY2026 GAAP EPS guidance from $9.97-$10.17 to $10.21-$10.31 vs $10.15 analyst estimate..
Quest Diagnostics (NYSE:DGX) raises FY2026 GAAP EPS guidance from $9.97-$10.17 to $10.21-$10.31 vs $10.15 analyst estimate..